Manish Gupta
Individual investor · data to Jun 2026
Disclosed value
₹1,146 Cr
Jun 2026 closes
At current prices
…
Current holdings
3
Tracked since
Jun 2019
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Indegene Ltd | 8.91% | flat | ₹1,092 Cr |
| Jagsonpal Pharmaceuticals Ltd | 3.08% | 0.36 | ₹48 Cr |
| Kimia Biosciences Ltd | 4.25% | flat | ₹6 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, Manish Gupta — an individual investor tracked through public shareholding filings — disclosed 3 holdings in Indian listed companies worth ₹1,146 crore. The same holdings-at-filing-value basis put it at ₹1,055 crore in Mar 2026 (+8.6%). Solomo carries these filings back to Jun 2019.
Largest disclosed positions in Jun 2026: Indegene Ltd (INDGN — 8.91% of the company, ₹1,092 crore); Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM — 3.08% of the company, ₹48 crore); Kimia Biosciences Ltd (KIMIABL — 4.25% of the company, ₹6 crore).
Changes in the Jun 2026 filings: Stake raised in Jagsonpal Pharmaceuticals Ltd (+0.36 pp). No longer disclosed after the previous quarter: Genus Prime Infra Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹1,146 Cr | +8.6% |
| Mar 2026 | ₹1,055 Cr | −9.7% |
| Dec 2025 | ₹1,168 Cr | −9.9% |
| Sep 2025 | ₹1,296 Cr | +1.8% |
| Jun 2025 | ₹1,273 Cr | +2.6% |
| Mar 2025 | ₹1,241 Cr | −3.9% |
| Dec 2024 | ₹1,292 Cr | −13.7% |
| Sep 2024 | ₹1,497 Cr | +23.4% |